Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare LtdfiledCriticalCadila Healthcare Ltd
Priority to MYPI20070333priorityCriticalpatent/MY142535A/en
Publication of MY142535ApublicationCriticalpatent/MY142535A/en
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems
(AREA)
Abstract
NOVEL HETEROCYCLIC COMPOUNDS THE PRESENT INVENTION RELATES TO NOVEL COMPOUNDS OF GENERAL FORMULA (1), THEIR REGIOISOMERS, TAUTOMERIC FORMS, NOVEL INTERMEDIATES INVOLVED IN THEIR SYNTHESIS, THE PRESENT INVENTION ALSO RELATES TO A PROCESS OF PREPARING COMPOUNDS OF GENERAL FORMULA (1), THEIR REGIOISOMERS, THEIR TAUTOMERIC FORMS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND NOVEL INTERMEDIATES INVOLVED IN THEIR SYNTHESIS. R2 X-(CH2)M R3- 0
MYPI200703332007-03-052007-03-05Tricyclic pyrazole derivatives as cannabinoid receptor modulators
MY142535A
(en)
DERIVATIVES OF 1,2,4-TRIAZOL AS MODULATORS OF MGLUR5 I, INTERMEDIARIES FOR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OF PAIN AND GASTROINTESTINAL DISORDERS